Telemedicine Special Registration Process Sign-On Letter to DEA
A letter to the Drug Enforcement Administration (DEA) signed by AAPA and its partners requesting a telemedicine special registration process to enable providers to safely prescribe controlled substances remotely.
Communication with White House in Relation to Federal COVID-19 Response
April 21, 2020 letter to President Donald Trump and Vice President Mike Pence.
Opioid Overdose Crisis Sign-On Letter
July 3, 2018. Letter to Jefferson B. Sessions, III re: Our Nation’s Opioid Overdose Crisis.
AAPA Letter to OMB re: FY19 Budget Proposal Inclusions Pertaining to the VA
December 19, 2017 letter to Mick Mulvaney.
AAPA Comments to FDA on Opioid Policy Steering Committee
December 28, 2017 letter to the U.S. Food and Drug Administration.
Letter to President’s Commission on Combating Drug Addiction and the Opioid Crisis
September 5, 2017. Letter to Governor Chris Christie and Members of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.